Randomized clinical trial of rapid versus 24-hour rehydration for children with acute gastroenteritis

Colin V E Powell1, Stephen J Priestley, Simon Young

  • 1Departments of aEmergency Medicine, Royal Children’s Hospital, Melbourne, Australia.

Pediatrics
|September 28, 2011
PubMed

Insights

Rapid nasogastric rehydration (RNR) and standard nasogastric rehydration (SNR) showed similar primary efficacy in treating children with acute viral gastroenteritis. RNR reduced hospitalizations but had a higher rate of failed ED discharges.

Area of Science:

  • Pediatric Emergency Medicine
  • Gastroenterology
  • Clinical Trials

Background:

  • Acute viral gastroenteritis is a common cause of dehydration in children.
  • Nasogastric rehydration is a key intervention for managing moderate dehydration.

Purpose of the Study:

  • To compare the efficacy of rapid nasogastric rehydration (RNR) versus standard nasogastric rehydration (SNR) in pediatric patients.
  • To evaluate treatment failure rates and clinical outcomes for two nasogastric rehydration regimens.

Main Methods:

  • A randomized controlled trial involving children aged 6-72 months with moderate dehydration due to acute viral gastroenteritis.
  • Patients received either RNR (4 hours in ED) or SNR (24 hours in ward).
  • Primary and secondary treatment failures were assessed.

Main Results:

  • Primary treatment failure rates were similar between RNR (11.8%) and SNR (9.2%).
  • Secondary treatment failure was significantly lower with RNR (30.3%) compared to SNR (44%).
  • RNR led to fewer hospitalizations, but approximately 23% of RNR patients failed discharge from the ED.

Conclusions:

  • Both RNR and SNR demonstrate comparable primary efficacy and clinical outcomes for pediatric acute viral gastroenteritis.
  • RNR effectively reduces the need for hospitalization but requires careful consideration of ED discharge success.
  • Further research may optimize RNR protocols to improve ED discharge success rates.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...